Inhibition of NF-κB activation and chemokine expression by the leukocyte glycoprotein, CD43, in colon cancer cells

International Journal of Oncology

Volumn 28, Issue 3, 2006, Pages 695-704

  Laos, Sirle ^a   Baeckström, Dan ^a   Hansson, Gunnar C ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Colon adenoma; Leukosialin; NF B; p65; Sialophorin

Indexed keywords

ALPHA CHEMOKINE; CCL2 PROTEIN, HUMAN; CHEMOKINE; CXCL1 PROTEIN, HUMAN; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 8; LEUKOSIALIN; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; NF KAPPAB INHIBITOR ALPHA; NF-KAPPAB INHIBITOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; SIGNAL PEPTIDE; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR ALPHA;

ACTIVE TRANSPORT; ARTICLE; CELL NUCLEUS; COLON TUMOR; DRUG ANTAGONISM; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; PATHOLOGY; TIME; TUMOR CELL LINE; WESTERN BLOTTING;

ACTIVE TRANSPORT, CELL NUCLEUS; ANTIGENS, CD43; BLOTTING, WESTERN; CELL LINE, TUMOR; CELL NUCLEUS; CHEMOKINE CCL2; CHEMOKINES; CHEMOKINES, CXC; COLONIC NEOPLASMS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; I-KAPPA B PROTEINS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; INTERLEUKIN-8; NF-KAPPA B; PPAR GAMMA; RNA, MESSENGER; TIME FACTORS; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33645212122     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.28.3.695     Document Type: Article

References (42)

1. Remold-O'Donnell E, Zimmerman C, Kenney D and Rosen FS: Expression on blood cells of sialophorin, the surface glycoprotein that is defective in Wiskott-Aldrich syndrome. Blood 70: 104-109, 1987.
2. Fernandez-Rodriguez J, Andersson CX, Laos S, Baeckstrom D, Sikut A, Sikut R and Hansson GC: The leukocyte antigen CD43 is expressed in different cell lines of non-hematopoietic origin. Tumour Biol 23: 193-201, 2002.
3. Santamaria M, Lopez-Beltran A, Toro M, Pena J and Molina IJ: Specific monoclonal antibodies against leukocyte-restricted cell surface molecule CD43 react with nonhematopoietic tumor cells. Cancer Res 56: 3526-3529, 1996.
4. Sikut R, Nilsson O, Baeckstrom D and Hansson GC: Colon adenoma and cancer cells aberrantly express the leukocyte-associated sialoglycoprotein CD43. Biochem Biophys Res Commun 238: 612-616, 1997. (Pubitemid 27464437)
5. Pimenidou A, Madden LA, Topping KP, Smith KA, Monson JR and Greenman J: Novel CD43 specific phage antibodies react with early stage colorectal tumours. Oncol Rep 11: 327-331, 2004.
6. Shelley CS, Remold-O'Donnell E, Davis AE, Bruns GA, Rosen FS, Carroll MC and Whitehead AS: Molecular characterization of sialophorin (CD43), the lymphocyte surface sialoglycoprotein defective in Wiskott-Aldrich syndrome. Proc Natl Acad Sci USA 86: 2819-2823, 1989. (Pubitemid 19112631)
7. Pallant A, Eskenazi A, Mattei MG, Fournier RE, Carlsson SR, Fukuda M and Frelinger JG: Characterization of cDNAs encoding human leukosialin and localization of the leukosialin gene to chromosome 16. Proc Natl Acad Sci USA 86: 1328-1332, 1989. (Pubitemid 19061539)
8. Ellies LG, Jones AT, Williams MJ and Ziltener HJ: Differential regulation of CD43 glycoforms on CD4+ and CD8+ T lymphocytes in graft-versus-host disease. Glycobiology 4: 885-893, 1994.
9. Sperling AI, Green JM, Mosley RL, Smith PL, Di Paolo RJ, Klein JR, Bluestone JA and Thompson CB: CD43 is a murine T cell costimulatory receptor that functions independently of CD28. J Exp Med 182: 139-146, 1995.
10. Cruz-Munoz ME, Salas-Vidal E, Salaiza-Suazo N, Becker I, Pedraza-Alva G and Rosenstein Y: The CD43 coreceptor molecule recruits the zeta-chain as part of its signaling pathway. J Immunol 171: 1901-1908, 2003.
11. Manjunath N, Correa M, Ardman M and Ardman B: Negative regulation of T-cell adhesion and activation by CD43. Nature 377: 535-538, 1995.
12. Onami T, Harrington LE, Williams MA, Galvan M, Larsen CP, Pearson TC, Manjunath N, Baum LG, Pearce BD and Ahmed R: Dynamic regulation of T cell immunity by CD43. J Immunol 168: 6022-6031, 2002. (Pubitemid 34620016)
13. Delon J, Kaibuchi K and Germain RN: Exclusion of CD43 from the immunological synapse is mediated by phosphorylation-regulated relocation of the cytoskeletal adaptor moesin. Immunity 15: 691-701, 2001.
14. Ostberg JR, Barth RK and Frelinger JG: The Roman god Janus: a paradigm for the function of CD43. Immunol Today 19: 546-550, 1998.
15. Remold-O'Donnell E and Rosen FS: Sialophorin (CD43) and the Wiskott-Aldrich syndrome. Immunodefic Rev 2: 151-174, 1990.
16. Lefebvre JC, Giordanengo V, Limouse M, Doglio A, Cucchiarini M, Monpoux F, Mariani R and Peyron JF: Altered glycosylation of leukosialin, CD43, in HIV-1-infected cells of the CEM line. J Exp Med 180: 1609-1617, 1994.
17. Zhang K, Baeckstrom D, Brevinge H and Hansson GC: Comparison of sialyl-Lewis a-carrying CD43 and MUC1 mucins secreted from a colon carcinoma cell line for E-selectin binding and inhibition of leukocyte adhesion. Tumour Biol 18: 175-187, 1997.
18. He YW and Bevan MJ: High level expression of CD43 inhibits T cell receptor/CD3-mediated apoptosis. J Exp Med 190: 1903-1908, 1999.
19. Andersson CX, Fernandez-Rodriguez J, Laos S, Sikut R, Sikut A, Baeckstrom D and Hansson GC: CD43 has a functional NLS, interacts with beta-catenin, and affects gene expression. Biochem Biophys Res Commun 316: 12-17, 2004.
20. Kadaja L, Laos S and Maimets T: Overexpression of leukocyte marker CD43 causes activation of the tumor suppressor proteins p53 and ARF. Oncogene 23: 2523-2530, 2004. (Pubitemid 38520749)
21. Remold-O'Donnell E, Kenney DM, Parkman R, Cairns L, Savage B and Rosen FS: Characterization of a human lymphocyte surface sialoglycoprotein that is defective in Wiskott-Aldrich syndrome. J Exp Med 159: 1705-1723, 1984. (Pubitemid 14117078)
22. Sikut R, Andersson CX, Sikut A, Fernandez-Rodriguez J, Karlsson NG and Hansson GC: Detection of CD43 (leukosialin) in colon adenoma and adenocarcinoma by novel monoclonal antibodies against its intracellular domain. Int J Cancer 82: 52-58, 1999. (Pubitemid 29266106)
23. Fukuda M and Carlsson SR: Leukosialin, a major sialoglyco-protein on human leukocytes as differentiation antigens. Med Biol 64: 335-343, 1986. (Pubitemid 17226776)
24. Cermak L, Simova S, Pintzas A, Horejsi V and Andera L: Molecular Mechanisms Involved in CD43-mediated apoptosis of TF-1 Cells. Roles of transcription Daxx expression and adhesion molecules. J Biol Chem 277: 7955-7961, 2002.
25. Mattioli I, Dittrich-Breiholts O, Kracht M, Livingstone M and Schmitz ML: A comparative analysis of T cell costimulation and CD43 activation reveals novel signaling pathways and target genes. Blood 104: 3302-3304, 2004.
26. Ghosh S and Karin M: Missing pieces in the NF-kappaB puzzle. Cell 109: S81-S96, 2002.
27. Kelly D, Campbell JI, King TP, Grant G, Jansson EA, Coutts AG, Pettersson S and Conway S: Commensal anaerobic gut bacteria attenuate inflammation by regulating nuclear-cytoplasmic shuttling of PPAR-gamma and RelA. Nat Immunol 5: 104-112, 2004.
28. Daniels MA, Hogquist KA and Jameson SC: Sweet 'n' sour: the impact of differential glycosylation on T cell responses. Nat Immunol 3: 903-910, 2002.
29. Santana MA, Pedraza-Alva G, Olivares-Zavaleta N, Madrid- Marina V, Horejsi V, Burakoff SJ and Rosenstein Y: CD43- mediated signals induce DNA-binding activity of AP-1, NF-AT and NFκB transcription factors in human T lymphocytes. J Biol Chem 275: 31460-31468, 2000.
30. Brown TJ, Shuford WW, Wang WC, Nadler SG, Bailey TS, Marquardt H and Mittler RS: Characterization of a CD43/ leukosialin-mediated pathway for inducing apoptosis in human T-lymphoblastoid cells. J Biol Chem 271: 27686-27695, 1996.
31. Ritchie MH, Fillmore RA, Lausch RN and Oakes JE: A role for NF-kappa B binding motifs in the differential induction of chemokine gene expression in human corneal epithelial cells. Invest Ophthalmol Vis Sci 45: 2299-2305, 2004.
32. Levy L, Neuveut C, Renard CA, Charneau P, Branchereau S, Gauthier F, van Nhieu JT, Cherqui D, Petit-Bertron AF, Mathieu D and Buendia MA: Transcriptional activation of interleukin- 8 by beta-catenin-Tcf4. J Biol Chem 277: 42386-42393, 2002.
33. Mestdagt M, Polette M, Buttice G, Noel A, Ueda A, Foidart JM and Gilles C: Transactivation of MCP-1/CCL2 by beta-catenin/ TCF-4 in human breast cancer cells. Int J Cancer 118: 135-142, 2005.
34. Deng J MS, Wang HY, Xia W, Wen Y, Zhou BP, Li Y, Lin SY and Hung MC: beta-catenin interacts with and inhibits NF-kappa B in human colon and breast cancer. Cancer Cell 2: 323-334, 2002. (Pubitemid 41043966)
35. Nesbit M, Schaider H, Miller TH and Herlyn M: Low-level monocyte chemoattractant protein-1 stimulation of monocytes leads to tumor formation in nontumorigenic melanoma cells. J Immunol 166: 6483-6490, 2001.
36. Dajee M, Lazarov M, Zhang JY, Cai T, Green CL, Russell AJ, Marinkovich MP, Tao S, Lin Q, Kubo Y and Khavari PA: NF-kappaB blockade and oncogenic Ras trigger invasive human epidermal neoplasia. Nature 421: 639-643, 2003.
37. Van Hogerlinden M, Rozell BL, Ahrlund-Richter L and Toftgard R: Squamous cell carcinomas and increased apoptosis in skin with inhibited Rel/nuclear factor-kappaB signaling. Cancer Res 59: 3299-3303, 1999.
38. Gapuzan ME, Yufit PV and Gilmore TD: Immortalized embryonic mouse fibroblasts lacking the RelA subunit of transcription factor NF-kappaB have a malignantly transformed phenotype. Oncogene 21: 2484-2492, 2002.
39. Ricca A, Biroccio A, Trisciuoglio D, Cippitelli M, Zupi G and Del Bufalo D: relA over-expression reduces tumorigenicity and activates apoptosis in human cancer cells. Br J Cancer 85: 1914-1921, 2001.
40. Cadoret A, Bertrand F, Baron-Delage S, Levy P, Courtois G, Gespach C, Capeau J and Cherqui G: Down-regulation of NF-kappaB activity and NF-kappaB p65 subunit expression by ras and polyoma middle T oncogenes in human colonic Caco-2 cells. Oncogene 14: 1589-1600, 1997.
41. Perkins ND: NF-kappaB: tumor promoter or suppressor? Trends Cell Biol 14: 64-69, 2004.
42. Campbell KJ, Rocha S and Perkins ND: Active repression of antiapoptotic gene expression by RelA(p65) NF-kappa B. Mol Cell 13: 853-865, 2004.